Regent Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-3,375
| Closed | -$307K | – | 210 |
|
|
2017
Q2 | $307K | Hold |
3,375
| – | – | 0.11% | 171 |
|
|
2017
Q1 | $296K | Hold |
3,375
| – | – | 0.11% | 167 |
|
|
2016
Q4 | $280K | Sell |
3,375
-75
| -2% | -$6.22K | 0.14% | 156 |
|
|
2016
Q3 | $319K | Hold |
3,450
| – | – | 0.17% | 143 |
|
|
2016
Q2 | $268K | Hold |
3,450
| – | – | 0.15% | 153 |
|
|
2016
Q1 | $285K | Hold |
3,450
| – | – | 0.16% | 147 |
|
|
2015
Q4 | $361K | Hold |
3,450
| – | – | 0.19% | 131 |
|
|
2015
Q3 | $363K | Hold |
3,450
| – | – | 0.2% | 128 |
|
|
2015
Q2 | $472K | Hold |
3,450
| – | – | 0.24% | 116 |
|
|
2015
Q1 | $430K | Hold |
3,450
| – | – | 0.22% | 122 |
|
|
2014
Q4 | $312K | Sell |
3,450
-150
| -4% | -$13.6K | 0.16% | 146 |
|
|
2014
Q3 | $260K | Hold |
3,600
| – | – | 0.13% | 159 |
|
|
2014
Q2 | $224K | Sell |
3,600
-190
| -5% | -$11.8K | 0.11% | 170 |
|
|
2014
Q1 | $259K | Buy |
3,790
+190
| +5% | +$13K | 0.14% | 158 |
|
|
2013
Q4 | $253K | Hold |
3,600
| – | – | 0.14% | 151 |
|
|
2013
Q3 | $260K | Sell |
3,600
-175
| -5% | -$12.6K | 0.17% | 138 |
|
|
2013
Q2 | $210K | Buy |
+3,775
| New | +$210K | 0.16% | 142 |
|